journal article·2018-10-31Open access

Generation of insulin-producing cells from human induced pluripotent stem cells on PLLA/PVA nanofiber scaffold

Seyed Ehsan Enderami, Mousa Kehtari, Mohammad Foad Abazari, Pegah Ghoraeian, Maryam Nouri Aleagha, Fatemeh Soleimanifar, Masoud Soleimani, Yousef Mortazavi, Samad Nadri, Hossein Mostafavi, Hassan Askari

Abstract

Pancreatic tissue engineering as a therapeutic option for restoring and maintenance of damaged pancreas function has a special focus to using synthetic Scaffolds. This study was designed to evaluate pancreatic differentiation of human induced pluripotent stem cells (hiPSCs) on poly-L-lactic acid and polyvinyl alcohol (PLLA/PVA) scaffolds as 3 D matrix. During differentiation process, morphology of cells gradually changed and iPSCs derived insulin producing cells (iPSCs-IPCs) formed spherical shaped cell aggregation that was the typical shape of islets of pancreas. The highly efficient differentiation of iPSCs into a relatively homogeneous population of IPCs was shown by immunostaining. Real-time reverse transcription polymerase chain reaction (RT-PCR) results demonstrated that iPSCs-IPCs expressed pancreas-specific transcription factors (Pdx1, insulin, glucagon and Ngn3). The expressions of these transcription factors in PLLA/PVA scaffold were significantly higher than 2 D groups. Furthermore, we showed that concentration of insulin and C-peptide in PLLA/PVA scaffold and/or 2 D culture in response to various concentrations of glucose increased but the difference between them were not significant. Altogether the current results demonstrated that PLLA/PVA scaffold could provide the microenvironment that promotes the pancreatic differentiation of iPSCs, up-regulate pancreatic-specific transcription factors and improved metabolic activity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pancreatic function and diabetes · Tissue Engineering and Regenerative Medicine · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Stem Cell Technology Research Center

Department of Medical Biotechnology and Nanotechnology, Zanjan University of Medical Sciences

School of Biology, College of Sciences, University of Tehran

Department of Genetics, Tehran Medical Sciences Branch, Islamic Azad University

Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences

Department of Hematology, Tarbiat Modares University

Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences

Department of Physiology, School of Medicine, Zanjan University of Medical Sciences

Department of Physiology, School of Medicine, International Campus, Tehran University of Medical Sciences

References (33)

Show source-provided references
1. 10.2337/diacare.27.10.256810.2337/diacare.27.10.2568 ↗
2. 10.2337/dc16-S00510.2337/dc16-S005 ↗
3. 10.1111/j.1600-6143.2011.03504.x10.1111/j.1600-6143.2011.03504.x ↗
4. 10.1038/nrgastro.2017.9310.1038/nrgastro.2017.93 ↗
5. 10.1016/j.biologicals.2016.12.00410.1016/j.biologicals.2016.12.004 ↗
6. 10.1002/jcp.2545910.1002/jcp.25459 ↗
7. 10.1007/s11892-017-0863-610.1007/s11892-017-0863-6 ↗
8. 10.3109/21691401.2013.86466210.3109/21691401.2013.864662 ↗
9. 10.1038/cr.2009.2810.1038/cr.2009.28 ↗
10. 10.1016/j.semcdb.2012.06.01010.1016/j.semcdb.2012.06.010 ↗
11. 10.1002/jcp.2572110.1002/jcp.25721 ↗
12. 10.1002/jcp.2089710.1002/jcp.20897 ↗
13. 10.1186/s13052-016-0273-410.1186/s13052-016-0273-4 ↗
14. 10.1089/ten.tea.2012.061510.1089/ten.tea.2012.0615 ↗
15. 10.1089/ten.teb.2013.046210.1089/ten.teb.2013.0462 ↗
16. 10.1002/jcp.2626610.1002/jcp.26266 ↗
17. 10.1002/jbm.a.3503910.1002/jbm.a.35039 ↗
18. 10.1002/jcp.2468310.1002/jcp.24683 ↗
19. 10.1080/21691401.2017.134592910.1080/21691401.2017.1345929 ↗
20. Fazili A, Gholami S, Zangi BM, et al. In vivo differentiation of mesenchymal stem cells into insulin producing cells on electrospun Poly-L-Lactide acid scaffolds coated with matricaria chamomilla L. Oil. Cell J. 2016;18:310.
21. 10.1016/j.msec.2015.12.08410.1016/j.msec.2015.12.084 ↗
22. 10.1002/app.2890410.1002/app.28904 ↗
23. 10.1002/jcb.2599610.1002/jcb.25996 ↗
24. 10.1080/21691401.2017.139699810.1080/21691401.2017.1396998 ↗
25. 10.1371/journal.pone.016307210.1371/journal.pone.0163072 ↗
26. 10.1016/j.tice.2014.11.00510.1016/j.tice.2014.11.005 ↗
27. 10.1007/s00441-015-2140-910.1007/s00441-015-2140-9 ↗
28. 10.1016/j.semcancer.2005.06.00910.1016/j.semcancer.2005.06.009 ↗
29. 10.1080/21691401.2017.135873310.1080/21691401.2017.1358733 ↗
30. 10.1080/21691401.2017.136792810.1080/21691401.2017.1367928 ↗
31. 10.1080/21691401.2017.133702610.1080/21691401.2017.1337026 ↗
32. 10.1080/21691401.2017.141639110.1080/21691401.2017.1416391 ↗
33. 10.1387/ijdb.052072hb10.1387/ijdb.052072hb ↗